Overview
Doxifluridine has been investigated for the treatment of Stomach Cancer.
Indication
主要用于乳腺癌、胃癌和大肠癌。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2011/07/25 | Phase 4 | Completed | |||
2006/02/27 | Phase 3 | Completed | |||
2006/02/27 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Doxifluridine Capsules | 国药准字H20000651 | 化学药品 | 胶囊剂 | 8/31/2020 | |
Doxifluridine Capsules | 国药准字H20020332 | 化学药品 | 胶囊剂 | 8/19/2024 | |
Doxifluridine Capsules | 国药准字H20010760 | 化学药品 | 胶囊剂 | 7/10/2020 | |
Doxifluridine Capsules | 国药准字H20050713 | 化学药品 | 胶囊剂 | 1/11/2020 | |
Doxifluridine Capsules | 国药准字H20030052 | 化学药品 | 胶囊剂 | 3/31/2020 | |
Doxifluridine Capsules | 国药准字H20041727 | 化学药品 | 胶囊剂 | 8/13/2020 | |
Doxifluridine Capsules | 国药准字H20010180 | 化学药品 | 胶囊剂 | 3/10/2020 | |
Doxifluridine Tablets | 国药准字H20031075 | 化学药品 | 片剂 | 5/22/2020 | |
Doxifluridine Tablets | 国药准字H20031267 | 化学药品 | 片剂 | 4/13/2020 | |
Doxifluridine Dispersible Tablets | 国药准字H20080306 | 化学药品 | 片剂 | 11/29/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.